Thank you for writing to us. One of our executive will reach back to you through your submitted medium. In case there’s an urgency, feel free to connect over WhatsApp for faster response.
Prefer calling? Dial +918265041513 (International callers) or +918265041513 (Indian callers).
Levoflox 500 mg contains Levofloxacin 500 mg, a broad-spectrum fluoroquinolone antibiotic used to treat a wide range of bacterial infections. It works by inhibiting bacterial DNA gyrase and topoisomerase IV enzymes, preventing bacterial DNA replication and leading to bacterial cell death.
Levoflox is prescribed for susceptible bacterial infections affecting the respiratory tract, urinary tract, skin, and soft tissues. It should only be used under the supervision of a qualified healthcare professional and is not effective against viral infections such as the common cold or influenza.
Common Indications:
Community-acquired pneumonia
Acute bacterial sinusitis
Acute exacerbation of chronic bronchitis
Urinary tract infections (UTIs)
Complicated urinary tract infections
Pyelonephritis (kidney infections)
Chronic bacterial prostatitis
Skin and soft tissue infections
Product Specifications
Brand Name
Levoflox 500 mg
Generic Name
Levofloxacin
Strength
500 mg
Dosage Form
Oral Tablets
Therapeutic Class
Fluoroquinolone Antibiotic
Route of Administration
Oral
Prescription Status
Prescription Only Medicine
Storage
Store below 25°C in a cool, dry place
Packaging
As supplied by the manufacturer
Key Features
Broad-spectrum antibacterial activity.
Effective against many respiratory and urinary tract bacterial pathogens.
High oral bioavailability with excellent tissue penetration.
Convenient once-daily dosing for many approved indications.
Suitable for treating both uncomplicated and complicated bacterial infections when clinically indicated.
Widely used in hospitals and outpatient settings.
Should be prescribed based on clinical evaluation and, whenever possible, culture and susceptibility testing.
Industry Update
The UAE continues to strengthen its antimicrobial stewardship initiatives to promote responsible antibiotic prescribing and reduce antimicrobial resistance. National guidance encourages healthcare professionals to prescribe antibiotics, including fluoroquinolones such as levofloxacin, only when clinically appropriate and to tailor therapy based on culture and susceptibility results whenever possible.
In Abu Dhabi and across the UAE, respiratory tract infections and urinary tract infections remain common reasons for antibiotic prescriptions. However, clinicians are increasingly selecting antibiotics according to local resistance patterns, with fluoroquinolones generally reserved for patients in whom they are appropriate and likely to be effective.
Healthcare providers are also emphasizing:
Judicious use of fluoroquinolones to help limit antimicrobial resistance.
Culture-guided therapy whenever feasible.
Patient education on completing the prescribed antibiotic course.
Monitoring for potential adverse effects and drug interactions during treatment.
As antimicrobial stewardship programs continue to expand throughout the UAE in 2026, Levofloxacin remains an important treatment option for selected bacterial respiratory and urinary tract infections when prescribed according to current clinical guidelines and susceptibility results.
Chat with us
Chat with us
